The Relationship Between Body Mass Index and Patient Outcomes in Low Flow Anaesthesia
Launched by BAKIRKOY DR. SADI KONUK RESEARCH AND TRAINING HOSPITAL · Oct 9, 2024
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a person's body weight, measured by Body Mass Index (BMI), affects their recovery and overall outcomes after major gynecological cancer surgery using a specific type of anesthesia called low flow anesthesia. The study aims to understand whether BMI plays a role in how well patients do after their surgery, helping doctors improve care and recovery for future patients.
To participate in this study, you need to be a woman aged 18 or older who is scheduled for major surgery related to gynecological cancers, such as cancers of the uterus, cervix, or ovaries. You should also be classified as ASA II-III, meaning you have a moderate health condition but are not severely ill. However, if you have certain medical issues, like serious heart or lung disease, or if you choose not to take part, you won't be eligible. This study is not yet recruiting participants, but if you qualify, you can expect to be monitored during your surgery and recovery, contributing valuable information to help improve patient care in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with ASA II-III
- • \>18 years
- • Patients undergoing major open surgery for endometrium, cervix or ovarian ca in gynaecological oncology clinic
- Exclusion Criteria:
- • Patients who refused to participate in the study
- • Cerebrovascular disease
- • Those with severe pulmonary disease
- • Those with serious cardiovascular disease
About Bakirkoy Dr. Sadi Konuk Research And Training Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital is a leading healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital combines clinical excellence with a robust research framework, focusing on innovative treatment methodologies and patient care. As a prominent clinical trial sponsor, it fosters collaboration among multidisciplinary teams to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. The institution is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported